Orthostatic hypotension: A review

Nephrol Ther. 2017 Apr:13 Suppl 1:S55-S67. doi: 10.1016/j.nephro.2017.01.003.

Abstract

Orthostatic hypotension, defined by a drop in blood pressure of at least 20mmHg for systolic blood pressure and at least 10mmHg for diastolic blood pressure within 3minutes of standing up, is a frequent finding, particularly in elderly patients. It is associated with a significant increase in morbidity and mortality. Although it is often multifactorial, the first favoring factor is medications. Other etiologies are divided in neurogenic orthostatic hypotension, characterized by autonomic failure due to central or peripheral nervous system disorders, and non-neurogenic orthostatic hypotension, mainly favoured by hypovolemia. Treatment always requires education of the patient regarding triggering situations and physiological countermanoeuvers. Pharmacological treatment may sometimes be necessary and mainly relies on volume expansion by fludrocortisone and/or a vasopressor agents such as midodrine. There is no predefined blood pressure target, the goal of therapy being the relief of symptoms and fall prevention.

Keywords: Autonomic nervous system; Baroreflex; Orthostatic hypotension; Synucleopathies.

Publication types

  • Review

MeSH terms

  • Aging
  • Anti-Inflammatory Agents / therapeutic use*
  • Drug Therapy, Combination
  • Fludrocortisone / therapeutic use*
  • Humans
  • Hypotension, Orthostatic / diagnosis
  • Hypotension, Orthostatic / drug therapy*
  • Hypotension, Orthostatic / etiology*
  • Hypovolemia / complications
  • Midodrine / therapeutic use*
  • Nervous System Diseases / complications
  • Sympathomimetics / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Sympathomimetics
  • Midodrine
  • Fludrocortisone